Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
sorafenib (nexavar) (1 trial)
Keloid (Phase 2)
Trials (2 total)
Trial APIs (2 total)